Creating a resource for studying pituitary neuroendocrine tumors

The National Biorepository and Resource for Pituitary Neuroendocrine Tumor Translational Research (BioPitNeT)

NIH-funded research University of Georgia · NIH-11249449

This study is looking at hormone-secreting tumors in the pituitary gland, especially Cushing’s disease, to better understand them and find new treatments that could help patients feel better and manage their condition more effectively.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Georgia NIH-funded
Lab location1 site (Athens, United States)
Project IDNIH-11249449 on NIH RePORTER

What this research studies

This research focuses on pituitary neuroendocrine tumors (PitNETs), particularly Cushing’s disease, which is caused by hormone-secreting tumors that lead to serious health issues. The project aims to establish a biorepository and deep tumor phenotyping platform to enhance understanding of these tumors and develop targeted therapies. By collecting and analyzing tumor samples, the research seeks to uncover the cellular and molecular complexities of PitNETs, ultimately improving treatment options and patient outcomes. Patients may benefit from improved therapies and better management of their condition as a result of this research.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with pituitary neuroendocrine tumors, particularly those suffering from Cushing’s disease.

Not a fit: Patients with other types of tumors or those not diagnosed with pituitary neuroendocrine tumors may not receive any benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for patients with pituitary neuroendocrine tumors, improving their quality of life and survival rates.

How similar studies have performed: While research on pituitary neuroendocrine tumors is limited, the establishment of biorepositories and deep phenotyping platforms has shown promise in other cancer research areas.

Where this research is happening

Athens, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.